Cite
Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
MLA
Jillian C. Bensko, et al. “Efficacy of Dupilumab in Patients with Aspirin-Exacerbated Respiratory Disease and Previous Inadequate Response to Anti-IL-5 or Anti-IL-5Rα in a Real-World Setting.” The Journal of Allergy and Clinical Immunology: In Practice, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb9777b54c10bb62994e8aedf8958fa1&authtype=sso&custid=ns315887.
APA
Jillian C. Bensko, Tanya M. Laidlaw, Anisha Mittal, Kathleen M. Buchheit, Deborah Gakpo, & Nicole Bavaro. (2021). Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting. The Journal of Allergy and Clinical Immunology: In Practice.
Chicago
Jillian C. Bensko, Tanya M. Laidlaw, Anisha Mittal, Kathleen M. Buchheit, Deborah Gakpo, and Nicole Bavaro. 2021. “Efficacy of Dupilumab in Patients with Aspirin-Exacerbated Respiratory Disease and Previous Inadequate Response to Anti-IL-5 or Anti-IL-5Rα in a Real-World Setting.” The Journal of Allergy and Clinical Immunology: In Practice, February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb9777b54c10bb62994e8aedf8958fa1&authtype=sso&custid=ns315887.